Fibromyalgia Clinical Trial
Official title:
Evaluation of Sleep Disordered Breathing and Autonomic Dysfunction in Fibromyalgia Through Peripheral Arterial Tonometry
Fibromyalgia syndrome (FMS) is characterized by the presence of widespread pain, chronic fatigue and typical sleep disturbances. The purpose of the current study is to investigate the nature of sleep disturbance in FMS, using a novel technology. Peripheral arterial tonometry is a method by which peripheral arterial tone is measured non - invasively using in an ambulatory setup during sleep. The information collected reflects autonomic nervous system function and respiratory changes during sleep. We intend to utilize this technique in order to improve our understanding of the interrupted patterns of sleep in FMS and as a possible biomarker which may be used in the future to follow up FMS patients and their response to treatment.
Fibromyalgia Syndrome (FMS) is a clinical entity characterized by the presence of chronic,
widespread pain and tenderness throughout the musculoskeletal system. FMS is considered to
be a prototype of central pan syndromes, conditions in which augmentation of pain processing
by the central nervous system in a major feature (1;2). As such, FMS overlaps with a number
of similar "functional" disorders, including TMJD, IBS, Interstitial cystitis, Gulf war
syndrome, chronic fatigue syndrome etc (3-5).
A major clinical feature of FMS is the presence of chronic fatigue, which is typically
accompanied by a severely disrupted sleep pattern. Difficulty falling asleep, frequent
awakening and non-refreshing sleep are all features classically reported by FMS patients. In
addition, a number of classic sleep disturbances have been identified among FMS patients
such as alpha - wave intrusion, disrupting normal stage IV sleep, as well as nocturnal falls
in oxygen saturation (6). Notably, disturbed sleep may contribute not only to chronic
fatigue, but also to enhanced pain processing as well as depression in FMS patients (7).
Thus, pain inhibitory functions of the CNS, such as the process of Diffuse Noxious
Inhibitory Control (DNIC) appear to be impaired in by sleep disruption (8).
Considerable interest has focused on the role of sleep apnea in FMS, as a possible factor
contributing to fatigue and pain. Overt obstructive sleep apnea has been diagnosed in some
patients (9) while more subtle disruptions of upper airway dynamics, such as increased upper
airway pressure, not leading to total airway collapse, has been detected in many patients
(10). Other researchers however have challenged the association of FMS with sleep apnea
(11).
Autonomic dysfunction is another important clinical manifestation of FMS with common
symptoms including presyncope / syncope, palpitations on standing and dizziness (12).
Postural Orthostatic Tachycardia Syndrome (POTS) is another autonomic disorder which
clinically overlaps with FMS (13).
Traditional polysomnography is a time-consuming and costly procedure, and hence, relatively
few FMS patients are formally evaluated for sleep disorders in clinical practice.
The Watch-PATTM100 is a non-invasive device, which utilizes peripheral arterial tone (PAT),
reflecting changes in autonomic nervous system function, as a marker for identifying and
documenting respiratory disturbances during sleep. The PAT signal is acquired through a
non-invasive probe attached to the finger during the sleep. Parameters measured include
oxygen saturation, heart rate, sleep and wake states, REM and non-REM sleep.
The purpose of the current study is to use Peripheral Arterial Tonometry (PAT) in order to
compare both disturbed sleep breathing and autonomic dysfunction in fibromyalgia patients
and healthy controls.
;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05659862 -
Digitally Assisted Behavioral Physical Activity Intervention in Fibromyalgia
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT03042728 -
Impact of Inclusion of a Therapy Dog Visit as Part of the Fibromyalgia Treatment Program
|
N/A | |
Recruiting |
NCT06097091 -
Effects and Mechanisms of Pain Neuroscience Education in Patients With Fibromyalgia
|
N/A | |
Recruiting |
NCT04554784 -
Effectiveness of Bowen Therapy for Pain Management in Patients With Fibromyalgia
|
N/A | |
Completed |
NCT03300635 -
Metabolism, Muscle Function and Psychological Factors in Fibromyalgia
|
N/A | |
Recruiting |
NCT06166563 -
Exercise, Irritable Bowel Syndrome and Fibromyalgia
|
N/A | |
Completed |
NCT03166995 -
Postural Exercises in Women With Fibromyalgia
|
N/A | |
Completed |
NCT03227952 -
Sensory Stimulation in Fibromyalgia
|
N/A | |
Recruiting |
NCT06237595 -
Vagus Nerve Stimulation in Fibromyalgia
|
N/A | |
Completed |
NCT01888640 -
Fibromyalgia Activity Study With Transcutaneous Electrical Nerve Stimulation (FAST)
|
N/A | |
Completed |
NCT03641495 -
Pain Education and Therapeutic Exercise for Fibromyalgia
|
N/A | |
Recruiting |
NCT05581628 -
FREQUENCY OF FIBROMYALGIA IN PATIENTS WITH CELIAC DISEASE
|
||
Active, not recruiting |
NCT05128162 -
Open-label Study to Assess the Safety and Efficacy of Psilocybin With Psychotherapy in Adult Participants With Fibromyalgia
|
Phase 2 | |
Completed |
NCT04674878 -
Comparison of Muscle Energy Techniques and Breathing Exercises for Functional Improvement in Fibromyalgia
|
N/A | |
Active, not recruiting |
NCT04084795 -
Augmentation of EMDR With tDCS in the Treatment of Fibromyalgia
|
N/A | |
Completed |
NCT03129906 -
Impact of the Restriction of Sources of Gluten in Fibromyalgia Patients
|
N/A | |
Completed |
NCT05058911 -
Exposure-based Cognitive Behavior Therapy vs Traditional Cognitive Behavior Therapy for Fibromyalgia
|
N/A | |
Recruiting |
NCT04571528 -
Effectiveness of VIRTUAL FIBROWALK STUDY
|
N/A | |
Recruiting |
NCT04571853 -
New Educational Tool for FM
|
N/A |